Company / EPS (Basic)
Entera Bio Ltd. EPS (Basic) History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Basic)
$0.25
FY2025
5-year range
$0.25 / $0.47
FY2022-FY2025
Trend
-19.4%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
EPS (Basic) has declined for 3 consecutive years, from $0.47 in FY2022 to $0.25 in FY2025.
Based on SEC 10-K filings.
0.25 in FY2025 with a 3-year CAGR of -19.0%.
Declined from $0.45 to $0.25 over the past 2 years.
EPS (Basic) over time
Growth rates
- 3-Year CAGR
- -19.0%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- Entera Bio Ltd.'s eps (basic) has declined for 3 consecutive years.
- In FY2025, eps (basic) decreased 19.4% year-over-year.
Company context
Key Data Points
- Altman Z-Score -0.83 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Basic)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.25 | -19.4% |
| FY2024 | $0.31 | -31.1% |
| FY2023 | $0.45 | -4.3% |
| FY2022 | $0.47 | - |
| FY2021 | - | - |
As of FY2025 · SEC 10-K Annual Filings · Updated Jun 24, 2026